Athenahealth seeks 1 million sq. ft headquarters
October 5, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsHealth information technology company athenahealth (Nasdaq: ATHN) is looking to triple the size of its current headquarters, to around 1 million square feet. “We’ve got to expand or move,” athenahealth CEO Jonathan Bush said. “These leases are 10 years, and we’ll need around that much space by then.”
$80M research facility to open at UMass Lowell
October 5, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsThe opening of the UMass Lowell’s 84,000-square-foot Emerging Technologies and Innovation Center (ETIC) is slated for next week will not only support the university, it will position UMass Lowell as an integral member of the regions life sciences cluster and ultimately become a powerful resource for the entire state.
Five deaths in meningitis outbreak linked to Mass. firm
October 5, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsThe death toll from an outbreak of a rare fungal meningitis, which has been traced back to a Framingham pharmacy, has reached five, and warnings have spread to 23 states.
VC tips on getting your consumer genetics startup funded
October 5, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsVenture capitalists at a panel at the Consumer Genetic Conference in Boston clearly know how they’re frequently seen by entrepreneurs. One used a slide of ogre-like old men in top hats as a visual aide for how companies see VCs. Another explicitly said told the audience “we’re not mean.” Steve Gullans, managing director at Excel Venture Management, said that if you talk to entrepreneurs, they usually say VCs “always have an opinion - it’s about their last great deal, or their last horrible deal, and somehow, it relates to you.”
RXi gets $300K SBIR grant for retinal cancer therapy
October 5, 2012 12:00 am | by Mass High Tech: The Journal of New England Technology | News | CommentsWestborough-based RXi Pharmaceuticals Corporation (OTC: RXII) has been awarded a $300,000 Small Business Innovation Research (SBIR) grant by the National Cancer Institute (NCI) to develop therapeutic RNAi compounds that can be self-delivered to more effectively treat a retinal cancer commonly affecting children.
Allergan back-tracks on Lap-Band for obese teens | MassDevice.com On Call
October 4, 2012 8:25 pm | by Mass Device | News | CommentsAllergan retracts efforts to win FDA approval to market its Lap-Band bariatric surgery MASSDEVICE ON CALL —Allergan (NYSE:AGN) pulled back on efforts to win FDA approval to market its Lap-Band weight-loss device to teens, the Los Angeles Times reported. Allergan has long had the FDA's OK to market the device to adults and doctors can already choose to prescribe Lap-Band treatment to younger patients with parent approval, but the aesthetics device maker can't legally market the weight-loss device to teenagers. News Well, Bariatrics, Food & Drug Administration (FDA), On Call, Weight lossread more
Low Cost, Highly Reliable, High-Voltage DC Power Supplies
October 4, 2012 5:00 pm | Trek, Inc. | Product Releases | CommentsTrek Inc., a designer and manufacturer of high-voltage power amplifiers and high-performance electrostatic instrumentation, will introduce a low cost, highly reliable, high-voltage DC power supply series...
State-of-the-Art Miniature Micropump for Air, Gas & Fluid Delivery
October 4, 2012 4:56 pm | Servoflo Corp. | Product Releases | CommentsServoflo Corporation of Lexington, Massachusetts is pleased to announce the MP-6 Series of micropumps. Based on piezoelectric diaphragm pump technology, the MP-6 micropump delivers air, gas or liquid...
High-Performance Universal Motion Controller/Drivers
October 4, 2012 4:52 pm | Newport Corporation | Product Releases | CommentsNewport Corporation, a worldwide leader in laser and photonic solutions that Make, Manage and Measure Light®, introduces the ultra high performance universal motion controller/driver, the XPS-Qx.
Mediware Receives Updated FDA Clearance for Core Blood Products
October 4, 2012 4:07 pm | by GLOBE NEWSWIRE | News | CommentsMediware Information Systems, Inc. (Nasdaq:MEDW) announced that the 2012 versions of the company's core blood management software products, including LifeTrak(R) and HCLL(R) Transfusion, have received updated 510(k) clearance by the US FDA. The software systems are used by more than 500 hospital and blood center facilities in the United States, Canada, Ireland, and Singapore...
Landauer, Inc. Appoints Greg Groenke To President Of IZI Medical Products
October 4, 2012 4:05 pm | by The Associated Press | News | CommentsLandauer, Inc. (NYSE: LDR), a recognized leader in personal and environmental radiation measurement and monitoring, outsourced medical physics services and high quality medical consumable accessories, today announced that it appointed Greg Groenke to President of Landauer's IZI Medical...
CONMED Corporation to Announce Third Quarter 2012 Financial Results on October 25, 2012
October 4, 2012 4:00 pm | by The Associated Press | News | CommentsCONMED Corporation (NASDAQ: CNMD) announced today that it expects to report third quarter 2012 financial results before the market opens on Thursday, October 25, 2012, and will also hold a conference call live over the Internet at 10:00 a.m. Eastern Time that same day. This webcast can be...
Biolase wins FDA nod for soft tissue laser
October 4, 2012 4:00 pm | by Mass Device | News | CommentsBiolase Inc. lands 510(k) clearance for its EPIC 10 diode soft tissue laser to improve patient comfort. California-based dental laser company Biolase (NSDQ:BIOL) touted FDA clearance and CE Mark approval for its EPIC 10 diode soft tissue laser to help dentists control the laser energy level and improve patient comfort. News Well, 510(k), CE Mark, Laser/Light-based Devicesread more
Tactile Systems Technology Announces Financing from Radius Ventures
October 4, 2012 3:58 pm | by The Associated Press | News | CommentsMINNEAPOLIS--(BUSINESS WIRE)--Oct 4, 2012--Tactile Systems Technology Inc., currently a leading provider of at-home lymphedema treatment, today announced it has secured $10.4 million of Series-B financing led by Radius Ventures. Galen Partners also participated in the round of financing. The...
Covidien lands U.S., Euro wins for bedside monitoring
October 4, 2012 3:15 pm | by Mass Device | News | CommentsCovidien lands 510(k) clearance for its Nellcor bedside respiratory patient monitoring system, which aims to reduce costs and service disruptions. Medical device company Covidien (NYSE:COV) landed FDA 510(k) clearance and European CE Mark approval for the Nellcor bedside respiratory patient monitoring system, which will help clinicians detect and respond to dangerous respiratory events sooner, the company said. News Well, 510(k), CE Mark, Regulatory/Compliance, Remote Patient Monitoring, Respiratoryread more


